{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:36:45Z","timestamp":1790811405512,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11427-021-2137-3","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:06:47Z","timestamp":1659168407000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria"],"prefix":"10.1007","volume":"66","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongmao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2137_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-26524-0","volume":"12","author":"KJ Adolfsen","year":"2021","unstructured":"Adolfsen, K.J., Callihan, I., Monahan, C.E., Greisen Per, J., Spoonamore, J., Momin, M., Fitch, L.E., Castillo, M.J., Weng, L., Renaud, L., et al. (2021). Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering. Nat Commun 12, 1\u20133.","journal-title":"Nat Commun"},{"key":"2137_CR2","first-page":"304","volume":"4","author":"N Al Hafid","year":"2015","unstructured":"Al Hafid, N., and Christodoulou, J. (2015). Phenylketonuria: a review of current and future treatments. Transl Pediatrics, 4, 304\u2013317.","journal-title":"Transl Pediatrics"},{"key":"2137_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","volume":"121","author":"DA Bilder","year":"2017","unstructured":"Bilder, D.A., Kobori, J.A., Cohen-Pfeffer, J.L., Johnson, E.M., Jurecki, E. R., and Grant, M.L. (2017). Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study. Mol Genet Metab 121, 1\u20138.","journal-title":"Mol Genet Metab"},{"key":"2137_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/10731198909118278","volume":"17","author":"L Bourget","year":"1989","unstructured":"Bourget, L., and Chang, T.M.S. (1989). Effects of oral administration of artificial cells immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats. Biomater Artif Cells Artif Organs 17, 161\u2013181.","journal-title":"Biomater Artif Cells Artif Organs"},{"key":"2137_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248\u2013254.","journal-title":"Anal Biochem"},{"key":"2137_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fmicb.2019.00410","volume":"10","author":"Y Cao","year":"2019","unstructured":"Cao, Y., Song, M., Li, F., Li, C., Lin, X., Chen, Y., Chen, Y., Xu, J., Ding, Q., and Song, H. (2019). A synthetic plasmid toolkit for Shewanella oneidensis MR-1. Front Microbiol 10, 410.","journal-title":"Front Microbiol"},{"key":"2137_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrd1659","volume":"4","author":"TMS Chang","year":"2005","unstructured":"Chang, T.M.S. (2005). Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 4, 221\u2013235.","journal-title":"Nat Rev Drug Discov"},{"key":"2137_CR8","doi-asserted-by":"publisher","first-page":"e0176286","DOI":"10.1371\/journal.pone.0176286","volume":"12","author":"KE Durrer","year":"2017","unstructured":"Durrer, K.E., Allen, M.S., and Hunt von Herbing, I. (2017). Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU. PLoS ONE 12, e0176286.","journal-title":"PLoS ONE"},{"key":"2137_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1501\/Eczfak_0000000330","volume":"28","author":"Y Duydu","year":"1999","unstructured":"Duydu, Y., S\u00dcZen, S., Vural, N., Erdem, N., Uysal, H. (1999). A modified method for determination of hippuric acid in urine by HPLC. Ankara Universitesi Eczacilik Fakultesi Dergisi, 28, 37\u201346.","journal-title":"Ankara Universitesi Eczacilik Fakultesi Dergisi"},{"key":"2137_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymben.2020.07.007","volume":"62","author":"AR Goormans","year":"2020","unstructured":"Goormans, A.R., Snoeck, N., Decadt, H., Vermeulen, K., Peters, G., Coussement, P., Van Herpe, D., Beauprez, J.J., De Maeseneire, S.L., and Soetaert, W.K. (2020). Comprehensive study on Escherichia coli genomic expression: does position really matter? Metab Eng 62, 10\u201319.","journal-title":"Metab Eng"},{"key":"2137_CR11","first-page":"275","volume":"35","author":"JA Hoskins","year":"1982","unstructured":"Hoskins, J.A., and Gray, J. (1982). Phenylalanine ammonia lyase in the management of phenylketonuria: the relationship between ingested cinnamate and urinary hippurate in humans. Res Commun Chem Pathol Pharmacol, 35, 275\u2013282.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"2137_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/bms.1200110609","volume":"11","author":"JA Hoskins","year":"1984","unstructured":"Hoskins, J.A., Holliday, S.B., and Greenway, A.M. (1984). The metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study. Biol Mass Spectrom 11, 296\u2013300.","journal-title":"Biol Mass Spectrom"},{"key":"2137_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(80)90944-7","volume":"315","author":"JA Hoskins","year":"1980","unstructured":"Hoskins, J.A., Jack, G., Peiris, R.J.D., Starr, D.J.T., Wade, H.E., Wright, E. C., and Stern, J. (1980). Enzymatic control of phenylalanine intake in phenylketonuria. Lancet 315, 392\u2013394.","journal-title":"Lancet"},{"key":"2137_CR14","unstructured":"Huisman, G.W., Agard, N.J., Mijts, B., Vroom, J., Zhang, X., Huisman, G., and Agard, N. (2014). New engineered polypeptide useful in pharmaceutical composition for treating phenylketonuria, has phenylalanine ammonia-lyase (PAL) activity, comprises specific amino acid sequence. US Patent, 2014314843-A1."},{"key":"2137_CR15","doi-asserted-by":"crossref","unstructured":"Hydery, T., and Coppenrath, V.A. (2019). A comprehensive review of pegvaliase, an enzyme substitution therapy for the treatment of phenylketonuria. Drug Target Insights 13.","DOI":"10.1177\/1177392819857089"},{"key":"2137_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5941\/MYCO.2011.39.4.257","volume":"39","author":"MW Hyun","year":"2011","unstructured":"Hyun, M.W., Yun, Y.H., Kim, J.Y., and Kim, S.H. (2011). Fungal and plant phenylalanine ammonia-lyase. Mycobiology 39, 257\u2013265.","journal-title":"Mycobiology"},{"key":"2137_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella, V.M., Ha, B.N., Castillo, M.J., Lubkowicz, D.J., Rowe, S.E., Millet, Y.A., Anderson, C.L., Li, N., Fisher, A.B., West, K.A., et al. (2018). Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol 36, 857\u2013864.","journal-title":"Nat Biotechnol"},{"key":"2137_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11814-008-0132-0","volume":"25","author":"DG Kang","year":"2008","unstructured":"Kang, D.G., Li, L., Ha, J.H., Choi, S.S., and Cha, H.J. (2008). Efficient cell surface display of organophosphorous hydrolase using N-terminal domain of ice nucleation protein in Escherichia coli. Korean J Chem Eng 25, 804\u2013807.","journal-title":"Korean J Chem Eng"},{"key":"2137_CR19","doi-asserted-by":"publisher","first-page":"eaau797","DOI":"10.1126\/scitranslmed.aau7975","volume":"11","author":"CB Kurtz","year":"2019","unstructured":"Kurtz, C.B., Millet, Y.A., Puurunen, M.K., Perreault, M., Charbonneau, M. R., Isabella, V.M., Kotula, J.W., Antipov, E., Dagon, Y., Denney, W.S., et al. (2019). An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med 11, eaau797.","journal-title":"Sci Transl Med"},{"key":"2137_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-7799(02)00006-9","volume":"21","author":"SY Lee","year":"2003","unstructured":"Lee, S.Y., Choi, J.H., and Xu, Z. (2003). Microbial cell-surface display. Trends Biotechnol 21, 45\u201352.","journal-title":"Trends Biotechnol"},{"key":"2137_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ymgme.2018.06.002","volume":"124","author":"HL Levy","year":"2018","unstructured":"Levy, H.L., Sarkissian, C.N., and Scriver, C.R. (2018). Phenylalanine ammonia lyase (PAL): from discovery to enzyme substitution therapy for phenylketonuria. Mol Genet Metab 124, 223\u2013229.","journal-title":"Mol Genet Metab"},{"key":"2137_CR22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/abbs\/gmab036","volume":"53","author":"Q Li","year":"2021","unstructured":"Li, Q., Sun, B., Chen, J., Zhang, Y., Jiang, Y., and Yang, S. (2021). A modified pCas\/pTargetF system for CRISPR-Cas9-assisted genome editing in Escherichia coli. Acta Biochim Biophys Sin 53, 620\u2013627.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2137_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1021\/ac202513u","volume":"84","author":"B Liang","year":"2012","unstructured":"Liang, B., Li, L., Mascin, M., and Liu, A. (2012). Construction of xylose dehydrogenase displayed on the surface of bacteria using ice nucleation protein for sensitive D-xylose detection. Anal Chem 84, 275\u2013282.","journal-title":"Anal Chem"},{"key":"2137_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40259-018-0292-3","volume":"32","author":"A Markham","year":"2018","unstructured":"Markham, A. (2018). Pegvaliase: first global approval. BioDrugs 32, 391\u2013395.","journal-title":"BioDrugs"},{"key":"2137_CR25","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1039\/D0CC00783H","volume":"56","author":"ZJ Mays","year":"2020","unstructured":"Mays, Z.J., Mohan, K., Trivedi, V.D., Chappell, T.C., and Nair, N.U. (2020). Directed evolution of Anabaena variabilis phenylalanine ammonia-lyase (PAL) identifies mutants with enhanced activities. Chem Commun 56, 5255\u20135258.","journal-title":"Chem Commun"},{"key":"2137_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00253-005-0111-x","volume":"70","author":"J Narita","year":"2006","unstructured":"Narita, J., Okano, K., Tateno, T., Tanino, T., Sewaki, T., Sung, M.H., Fukuda, H., and Kondo, A. (2006). Display of active enzymes on the cell surface of Escherichia coli using PgsA anchor protein and their application to bioconversion. Appl Microbiol Biotechnol 70, 564\u2013572.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2137_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s42255-021-00430-7","volume":"3","author":"MK Puurunen","year":"2021","unstructured":"Puurunen, M.K., Vockley, J., Searle, S.L., Sacharow, S.J., Phillips Iii, J.A., Denney, W.S., Goodlett, B.D., Wagner, D.A., Blankstein, L., Castillo, M.J., et al. (2021). Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1\/2a study. Nat Metab 3, 1125\u20131132.","journal-title":"Nat Metab"},{"key":"2137_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00284-015-0781-2","volume":"70","author":"W Qu","year":"2015","unstructured":"Qu, W., Xue, Y., and Ding, Q. (2015). Display of fungi xylanase on Escherichia coli cell surface and use of the enzyme in xylan biodegradation. Curr Microbiol 70, 779\u2013785.","journal-title":"Curr Microbiol"},{"key":"2137_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1094\/MPMI-20-3-0313","volume":"20","author":"RS Ravirala","year":"2007","unstructured":"Ravirala, R.S., Barabote, R.D., Wheeler, D.M., Reverchon, S., Tatum, O., Malouf, J., Liu, H., Pritchard, L., Hedley, P.E., Birch, P.R.J., et al. (2007). Efflux pump gene expression in Erwinia chrysanthemi is induced by exposure to phenolic acids. Mol Plant Microbe Interact 20, 313\u2013320.","journal-title":"Mol Plant Microbe Interact"},{"key":"2137_CR30","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","volume":"96","author":"CN Sarkissian","year":"1999","unstructured":"Sarkissian, C.N., Shao, Z., Blain, F., Peevers, R., Su, H., Heft, R., Chang, T. M.S., and Scriver, C.R. (1999). A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci USA 96, 2339\u20132344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2137_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ymgme.2019.02.001","volume":"126","author":"N Smith","year":"2019","unstructured":"Smith, N., Longo, N., Levert, K., Hyland, K., and Blau, N. (2019). Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers. Mol Genet Metab 126, 406\u2013412.","journal-title":"Mol Genet Metab"},{"key":"2137_CR32","doi-asserted-by":"publisher","first-page":"fnw212","DOI":"10.1093\/femsle\/fnw212","volume":"363","author":"U Sonnenborn","year":"2016","unstructured":"Sonnenborn, U. (2016). Escherichia coli strain Nissle 1917\u2014from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties. FEMS Microbiol Lett 363, fnw212.","journal-title":"FEMS Microbiol Lett"},{"key":"2137_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s11427-020-1744-6","volume":"65","author":"S Yin","year":"2022","unstructured":"Yin, S., Ma, L., Shao, T., Zhang, M., Guan, Y., Wang, L., Hu, Y., Chen, X., Han, H., Shen, N., et al. (2022). Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor. Sci China Life Sci 65, 718\u2013730.","journal-title":"Sci China Life Sci"},{"key":"2137_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2010.125","volume":"6","author":"FJ van Spronsen","year":"2010","unstructured":"van Spronsen, F.J. (2010). Phenylketonuria: a 21st century perspective. Nat Rev Endocrinol 6, 509\u2013514.","journal-title":"Nat Rev Endocrinol"},{"key":"2137_CR35","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1021\/ie101973h","volume":"50","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Jia, X., Wang, L., Liu, J., and Ma, G. (2011). Preparation of Ca-Alginate microparticles and its application for phenylketonuria oral therapy. Ind Eng Chem Res 50, 4106\u20134112.","journal-title":"Ind Eng Chem Res"},{"key":"2137_CR36","doi-asserted-by":"publisher","first-page":"e0160367","DOI":"10.1371\/journal.pone.0160367","volume":"11","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Tang, R., Bian, L., Mei, M., Li, C., Ma, X., Yi, L., and Ma, L. (2016). Surface immobilization of human arginase-1 with an engineered ice nucleation protein display system in E. coli. PLoS ONE 11, e0160367.","journal-title":"PLoS ONE"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-2137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-021-2137-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-2137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:56:37Z","timestamp":1744203397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-021-2137-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s11427-021-2137-3","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}